However, concerns have been raised over the safety of pregnant women using GLP-1 receptor agonists
A brief description of this section is listed in Table 7
In the 58.3% of patients with vomiting at baseline, all three endpoints also improved and, in addition, there was reduction in the composite score of nausea, abdominal pain, bloating and early satiety [123,124,125,126]
Technical Specifications Storage & Quality Assurance Strict adherence to climate-controlled, cold-chain storage is mandatory to preserve the structural integrity of this compound
We will choose the right ones for you
Outcomes depend on adherence, dosing, and lifestyle factors